Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2018; 28 (1): 74-75
Dans Anglais | IMEMR | ID: emr-193014

Résumé

Percutaneous nephrolithotomy has a success rate of 90%; however, its overall complication rate is approximately 83%, including urinary extravasation, bleeding necessitating transfusion, and postoperative fever. Septicemia, colonic and pleural injury are rare major complications. Neighboring organ injury, especially colonic injury, is frequently seen during tract dilatation procedure. In this study, we report a case of colonic lumbar hernia, which is a rare complication of percutaneous nephrolithotomy

2.
IJRM-Iranian Journal of Reproductive Medicine. 2012; 10 (4): 363-372
Dans Anglais | IMEMR | ID: emr-132389

Résumé

Osteoporosis is a chronic disease characterized by a decrease in bone mineral density [BMD] and corruption of the microarchitectural structure of bone tissue. It was investigated whether methylprednisolone had a favorable effect on osteoporotic bone tissue in Oophorectomy induced osteoporotic rats whose endogenous adrenaline levels are suppressed with metyrosine. Bone Mineral Density, number of osteoblast-osteoclast, bone osteocalcin levels and alkaline phosphatase [ALP] measurements were performed. Obtained results were compared with that of alendronate. Oophorectomy induced osteoporosis was exacerbated by methylprednisolone. Alentronate prevented ovariectomised induced osteoporosis, but it couldn't prevent methylprednisolone +ovariectomised induced osteoporosis in rats. Combined treatment with methylprednisolon and metyrosine was the best treatment for preventing osteoporosis but metyrosine alone couldn't prevent osteoporosis in ovariectomised rats


Sujets)
Femelle , Animaux de laboratoire , Méthyltyrosines , Rats , Ostéoclastes/effets des médicaments et des substances chimiques , Prednisolone , Prednisolone/effets indésirables , Association médicamenteuse , Ovariectomie/effets indésirables , Ostéoblastes/effets des médicaments et des substances chimiques , Densité osseuse/effets des médicaments et des substances chimiques , Méthylprednisolone/effets indésirables , Méthylprednisolone , Ostéocalcine/effets des médicaments et des substances chimiques , Phosphatase alcaline , Alendronate , Résultat thérapeutique
SÉLECTION CITATIONS
Détails de la recherche